End-of-year final results for AMS were good. Share price jumped from about £1.10 to £1.18. This could be the stimulus the share needed as its been quiet this year so far. Personally I’m going to wait for the next buy signal which, I accept, may mean missing on a good up.
As a reminder AMS are a medical technology company that sell advanced wound care products.
The Group operates mainly in the UK, the Netherlands, Germany, the Czech Republic and Russia, with a sales office located in the USA.
They are debt free and, founded in 1991, they employ 450.
Sales and net profit have increased nicely and profit margin is steady. However, administrative cost is high, slightly, as is inventory. They have a new Chairman and the CEO sold a substantial amount of shares in AMS yesterday. So, I’m waiting and will of course let you know when a strong buy signal happens.